Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

FARN

Faron Pharmaceuticals Oy (FARN)

Faron Pharmaceuticals Oy
일자:
정렬 기준:
 검색 관련기사 보기:LSE:FARN
일자시간출처헤드라인심볼기업
2024/12/0217:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Interactions with UK Regulatory AuthoritiesLSE:FARNFaron Pharmaceuticals Oy
2024/11/2720:29Alliance NewsAlliance NewsFaron announces promising findings from blood cancer drug trialLSE:FARNFaron Pharmaceuticals Oy
2024/11/2716:00RNS Regulatory NewsFaron Pharmaceuticals Oy Positive Phase 2 Interim Results from BEXMAB TrialLSE:FARNFaron Pharmaceuticals Oy
2024/11/1116:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Targeting Soluble Clever-1 for Autoimmune DiseasesLSE:FARNFaron Pharmaceuticals Oy
2024/11/0516:00RNS Regulatory NewsFaron Pharmaceuticals Oy Shareholders’ Nomination BoardLSE:FARNFaron Pharmaceuticals Oy
2024/10/2215:00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron’s Capital Markets Day 2024LSE:FARNFaron Pharmaceuticals Oy
2024/10/0715:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Faron announces Capital Markets DayLSE:FARNFaron Pharmaceuticals Oy
2024/08/3015:00RNS Regulatory NewsFaron Pharmaceuticals Oy Grant of optionsLSE:FARNFaron Pharmaceuticals Oy
2024/08/2719:08Alliance NewsAlliance NewsFaron Pharma shares surge as US FDA grants fast track designationLSE:FARNFaron Pharmaceuticals Oy
2024/08/2715:00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron 2024 Half-Year Financial ResultsLSE:FARNFaron Pharmaceuticals Oy
2024/08/2715:00RNS Regulatory NewsFaron Pharmaceuticals Oy FDA Grants Fast Track Designation for BexmarilimabLSE:FARNFaron Pharmaceuticals Oy
2024/08/2015:00RNS Regulatory NewsFaron Pharmaceuticals Oy Notice of Half-Year Financial ResultsLSE:FARNFaron Pharmaceuticals Oy
2024/08/1321:23Alliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals joins US grant for battlefield woundsLSE:FARNFaron Pharmaceuticals Oy
2024/08/1315:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Traumakine Research Collaboration and DoD GrantLSE:FARNFaron Pharmaceuticals Oy
2024/08/1220:01Alliance NewsAlliance NewsEXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRxLSE:FARNFaron Pharmaceuticals Oy
2024/08/0815:00RNS Regulatory NewsFaron Pharmaceuticals Oy Appointment of Chief Financial OfficerLSE:FARNFaron Pharmaceuticals Oy
2024/08/0718:00RNS Regulatory NewsFaron Pharmaceuticals Oy Grant of optionsLSE:FARNFaron Pharmaceuticals Oy
2024/08/0700:51Alliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals names Petri Bono as CMOLSE:FARNFaron Pharmaceuticals Oy
2024/08/0616:30RNS Regulatory NewsFaron Pharmaceuticals Oy Faron Appoints Dr. Petri Bono as new CMOLSE:FARNFaron Pharmaceuticals Oy
2024/07/1203:23Alliance NewsAlliance NewsTRADING UPDATES: Titon warns on trading; Videndum revenue in-lineLSE:FARNFaron Pharmaceuticals Oy
2024/07/1115:00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron Announces Positive FDA FeedbackLSE:FARNFaron Pharmaceuticals Oy
2024/06/2522:00RNS Regulatory NewsFaron Pharmaceuticals Oy Update on settlementLSE:FARNFaron Pharmaceuticals Oy
2024/06/2518:30RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in Company - ReplacementLSE:FARNFaron Pharmaceuticals Oy
2024/06/2420:45RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
2024/06/2420:45RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
2024/06/2420:45RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
2024/06/2420:45RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
2024/06/2021:00RNS Regulatory NewsFaron Pharmaceuticals Oy New shares registered with Finnish Trade RegisterLSE:FARNFaron Pharmaceuticals Oy
2024/06/2015:00RNS Regulatory NewsFaron Pharmaceuticals Oy Fully subscribed EUR 30.7 million share offeringLSE:FARNFaron Pharmaceuticals Oy
2024/06/0516:00RNS Regulatory NewsFaron Pharmaceuticals Oy Proposed REX Retail OfferLSE:FARNFaron Pharmaceuticals Oy
 검색 관련기사 보기:LSE:FARN